Physiological responses and microbiota shifts after spermidine administration as a postbiotic on rodents fed a high-fat high-fructose diet
Beneficial Microbes · 2024
DOI: 10.1163/18762891-bja00029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Beneficial Microbes, 2024. Verfasst von N C O Melo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Program in Nutrition at the Federal University of Pernambuco, 50740-600, Pernambuco, Brazil. Hauptthemen laut MEDLINE: Spermidine, Diet, High-Fat, Rats, Wistar, Fructose. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The consumption of a high-fat high-fructose diet partly resemble the western dietary patterns, which is closely associated with excessive body adiposity and metabolic disorders, such as obesity and type 2 diabetes. Moreover, this unhealthy regime produces unfavourable changes on the faecal microbiota, potentially interfering with microorganisms postbiotic function, such as spermidine, a natural polyamine that has been involved in the control of weight gain. The study aimed to analyse the repercussions of spermidine supplementation on somatic measurements, metabolic markers, and the faecal microbiota profile of rats fed a diet rich in fat and fructose. Indeed, Wistar males with oral administration of spermidine (20 mg/kg/day) for 6 weeks were evaluated for food and energy intake, biochemical markers, and faecal microbiota signatures. The daily use of spermidine decreased weight gain ( ), reduced feed efficiency ( ), and attenuated visceral fat deposition ( ), although no effect on energy intake, hepatic weight, triglyceride and glucose index and atherogenic indexes. Similarly, the consumption of spermidine partially restored the presence of microbial species, notably Akkermansia muciniphila . Elevated concentrations of this species were linked to a decrease in triglycerides ( ), indicating that the supplementation of spermidine might contribute to managing energy fuel homeostasis in association with an obesogenic diet.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Postgraduate Program in Nutrition at the Federal University of Pernambuco, 50740-600, Pernambuco, Brazil.
- Capes Foundation, Ministry of Education, Brasilia-DF, Brazil.
- Precision Nutrition and Cardiometabolic Health, IMDEA-Alimentacion Institute (Madrid Institute for Advanced Studies), Campus of International Excellence (CEI), UAM + CSIC, 28049 Madrid, Spain.
- Nutrition and Obesity Group, Department of Nutrition and Food Science, Faculty of Pharmacy and Lucio Lascaray Research Centre, University of the Basque Country (UPV/EHU), 01006 Vitoria-Gasteiz, Spain.
- CIBERobn Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, 28222 Madrid, Spain.
- BIOARABA Health Research Institute, 01006 Vitoria-Gasteiz, Spain.
ORCID-Profile: N C O Melo, A Cuevas-Sierra, L Arellano-Garcia, M P Portillo, I Milton-Laskibar, J A Martinez
Zitieren
APA
Melo, N. C. O., Cuevas-Sierra, A., Casillas-Fikentscher, A., Arellano-Garcia, L., Portillo, M. P., Milton-Laskibar, I., & Martinez, J. A. (2024). Physiological responses and microbiota shifts after spermidine administration as a postbiotic on rodents fed a high-fat high-fructose diet. Beneficial Microbes. https://doi.org/10.1163/18762891-bja00029
Vancouver
Melo NCO, Cuevas-Sierra A, Casillas-Fikentscher A, Arellano-Garcia L, Portillo MP, Milton-Laskibar I, et al. Physiological responses and microbiota shifts after spermidine administration as a postbiotic on rodents fed a high-fat high-fructose diet. Beneficial Microbes. 2024. doi:10.1163/18762891-bja00029
BibTeX
@article{Melo2024,
author = {Melo, N C O and Cuevas-Sierra, A and Casillas-Fikentscher, A and Arellano-Garcia, L and Portillo, M P and Milton-Laskibar, I and Martinez, J A},
title = {Physiological responses and microbiota shifts after spermidine administration as a postbiotic on rodents fed a high-fat high-fructose diet},
journal = {Beneficial Microbes},
year = {2024},
doi = {10.1163/18762891-bja00029}
}
EUVIMED